Source: Medical Device Week, Feb 14, 2005 pNA.
Title: Report cites high patient costs in drug trials.(Brief Article)
Subjects:
Medical care, Cost of - Surveys
Clinical trials - Surveys
Locations: United States
Electronic Collection: A131872945
RN: A131872945
Full Text COPYRIGHT 2005 Thomson Healthcare, Inc.
Report cites high patient costs in drug trials
The average per-patient cost of clinical trials ranges from roughly $5,500 at Phase I to $7,600 in Phase III, according to a recent study by pharmaceutical
market research company, Cutting Edge Information (Research Triangle Park,
North Carolina). The report states that a drug company spends an
average of 37% of its overall R&D budget on clinical affairs.
Cutting Edge said that some of the companies it surveyed have 2004 clinical
affairs budgets exceeding $400 million.
It said that clinical affairs executives rank patient recruitment as the No. 1 area where the industry can accelerate clinical trials, which on average, consumes 30% of the overall clinical trial process.
SOURCE-Medical Device Daily